Medical Technology

Gilead states that its HIV Drug Counterfeiting Network has sold 250 million worth of HIV Drugs

Gilead Sciences Inc stated Tuesday that counterfeit and altered HIV treatments worth $250 million were offered to pharmacies by a network distributors and suppliers over two years.

In August, the drugmaker disclosed that Descovy and Biktarvy distributors that were not authorized to sell Gilead’s HIV treatments have sold counterfeits to pharmacies. These counterfeit Gilead bottles were altered with foil induction labels or labels , and contained tablets that were not correct.

“After becoming aware of counterfeit Gilead HIV medication being sold, we informed federal law enforcement authorities including the FDA as well as pharmacies that dispense the medicine, and immediately took legal action,” a Gilead spokesperson announced on Tuesday.

Gilead said that the distributors against whom it filed a lawsuit it had sold 85,247 bottles counterfeit HIV drugs.

Reporting by Manas Mishrira in Bengaluru; Editing By Amy Caren Daniel

Content Source: https://www.medscape.com/viewarticle/966780?src=rss

The Medical Progress

The Medical Progress is here to provide news for the medical industry on a daily basis which are mainly on the medical cannabis and it’s legalisation.

Related Articles

Close